In Parliament

No specific assessment has been made.

In 2021/22, North East London Integrated Care System (ICS) was allocated £460,000 for programmes which included the introduction of mid-care

In April 2022, the Government published guidance for the public and for employers reducing the risk of catching and spreading respiratory il

Following its initial findings in June 2021, the FDA issued a subsequent statement confirming that after detailed analysis, these events wer

NHS England has appointed a National Clinical Director for eye care to oversee the recovery and longer-term transformation of eye care servi

On 1 October 2022, the core functions of the Vaccine Taskforce (VTF) merged with the UK Health Security Agency (UKHSA) and the Office for Li

The Department continues to plan and prepare for a range of pandemic and emerging infectious disease scenarios, including those caused by re

Through the implementation of the HIV Action Plan, we are considering how access to pre-exposure prophylaxis (PrEP) can be improved, includi

We are considering actions to ensure that the sexual health workforce has the capacity required to meet the sexual and reproductive health n

Since 1 May 2022, the UK Health Security Agency has procured all available stock of the smallpox vaccines Imvanex and JYNNEOS.